Home/Filings/4/0001005201-19-000045
4//SEC Filing

Bukofzer Stan 4

Accession 0001005201-19-000045

CIK 0001005201other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:01 AM ET

Size

5.1 KB

Accession

0001005201-19-000045

Insider Transaction Report

Form 4
Period: 2019-03-14
Bukofzer Stan
Chief Medical Officer & SVP***
Transactions
  • Purchase

    Common Stock

    2019-03-14$4.13/sh+5,000$20,6585,000 total
Footnotes (1)
  • [F1]The price reported is a weighted average purchase price. The shares were purchased in multiple same-way transactions on March 14, 2019 at prices ranging from $4.123 to $4.133 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock purchased at each separate price.

Issuer

Assertio Therapeutics, Inc

CIK 0001005201

Entity typeother

Related Parties

1
  • filerCIK 0001663041

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:01 AM ET
Size
5.1 KB